Furthermore, UTMD‐mediated BMP9 delivery restored the anti‐tumour function of NK cells administered in combination with a PD‐L1 inhibitor to suppress tumour growth in an HBV‐infected HCC xenograft model. The gene discussed is GDF2; the disease is neoplasm.